Location: Dallas, TX
CIK: 0001791827 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $1.018B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNTH | DIANTHUS THERAPEUTICS INC | 2,873,000 | $62.63M | 6.2% | $18.09 | +42.2% | COM | 252828108 |
| BSX | BOSTON SCIENTIFIC CORP | 515,000 | $46M | 4.5% | $49.10 | +79.3% | COM | 101137107 |
| JANX | JANUX THERAPEUTICS INC | 741,900 | $39.72M | 3.9% | $39.67 | +33.3% | COM | 47103J105 |
| NTRA | NATERA INC | 223,800 | $35.43M | 3.5% | $55.01 | +164.8% | COM | 632307104 |
| EXAS | EXACT SCIENCES CORP | 603,011 | $33.88M | 3.3% | $55.79 | +11.6% | COM | 30063P105 |
| ISRG | INTUITIVE SURGICAL INC | 64,800 | $33.82M | 3.3% | $351.77 | +48.1% | COM NEW | 46120E602 |
| CGON | CG ONCOLOGY INC | 1,097,800 | $31.48M | 3.1% | $39.58 | -13.6% | COM | 156944100 |
| UNH | UNITEDHEALTH GROUP INC | 60,000 | $30.35M | 3.0% | $548.30 | +0.8% | COM | 91324P102 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 220,400 | $30.08M | 3.0% | $96.63 | +28.0% | COM | 64125C109 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,126,700 | $28.96M | 2.8% | $26.67 | +6.1% | COM | 45166A102 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 234,500 | $28.88M | 2.8% | $142.84 | -17.5% | SHS USD | G50871105 |
| MIRM | MIRUM PHARMACEUTICALS INC | 666,200 | $27.55M | 2.7% | $27.38 | +52.2% | COM | 604749101 |
| ACHC | ACADIA HEALTHCARE COMPANY IN | 658,000 | $26.09M | 2.6% | $72.97 | -38.2% | COM | 00404A109 |
| ARVN | ARVINAS INC | 1,358,000 | $26.03M | 2.6% | $47.79 | -49.2% | COM | 04335A105 |
| GKOS | GLAUKOS CORP | 170,000 | $25.49M | 2.5% | $101.65 | +35.5% | COM | 377322102 |
| DXCM | DEXCOM INC | 318,000 | $24.73M | 2.4% | $113.20 | -34.6% | COM | 252131107 |
| TMO | THERMO FISHER SCIENTIFIC INC | 44,600 | $23.2M | 2.3% | $529.04 | +3.5% | COM | 883556102 |
| HUM | HUMANA INC | 89,200 | $22.63M | 2.2% | $348.89 | -24.4% | COM | 444859102 |
| KYMR | KYMERA THERAPEUTICS INC | 500,000 | $20.11M | 2.0% | $44.16 | +2.3% | COM | 501575104 |
| AVTR | AVANTOR INC | 947,000 | $19.95M | 2.0% | $21.56 | +4.3% | COM | 05352A100 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,500,000 | $19.83M | 1.9% | $18.49 | -7.4% | COM | 87164F105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,165,800 | $19.53M | 1.9% | $15.99 | — | SPONSORED ADS | 152309100 |
| RVMD | REVOLUTION MEDICINES INC | 446,200 | $19.52M | 1.9% | $30.74 | +64.2% | COM | 76155X100 |
| XENE | XENON PHARMACEUTICALS INC | 474,000 | $18.58M | 1.8% | $37.48 | +10.3% | COM | 98420N105 |
| THC | TENET HEALTHCARE CORP | 137,000 | $17.29M | 1.7% | $51.02 | +191.4% | COM NEW | 88033G407 |
| INSM | INSMED INC | 232,800 | $16.07M | 1.6% | $48.37 | +48.9% | COM PAR $.01 | 457669307 |
| AXSM | AXSOME THERAPEUTICS INC | 188,000 | $15.91M | 1.6% | $55.95 | +64.4% | COM | 05464T104 |
| — | BLUEPRINT MEDICINES CORP | 176,600 | $15.4M | 1.5% | $57.39 | — | COM | 09627Y109 |
| DHR | DANAHER CORPORATION | 67,000 | $15.38M | 1.5% | $217.74 | +12.0% | COM | 235851102 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 352,000 | $14.81M | 1.5% | $51.17 | -3.1% | COM | 90400D108 |
| ILMN | ILLUMINA INC | 109,700 | $14.66M | 1.4% | $133.40 | +6.8% | COM | 452327109 |
| ABBV | ABBVIE INC | 80,700 | $14.34M | 1.4% | $139.64 | +27.1% | COM | 00287Y109 |
| ARVN | ARVINAS INC | 700,000 | $13.42M | 1.3% | $47.79 | -49.2% | Call | 04335A105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,053,300 | $13.24M | 1.3% | $17.88 | -15.8% | COM | 77313F106 |
| BMY | BRISTOL-MYERS SQUIBB CO | 215,000 | $12.16M | 1.2% | $43.65 | +20.5% | COM | 110122108 |
| TMDX | TRANSMEDICS GROUP INC | 192,400 | $12M | 1.2% | $101.84 | -8.6% | COM | 89377M109 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,390,100 | $11.29M | 1.1% | $20.69 | -40.2% | COM | 71722W107 |
| SGRY | SURGERY PARTNERS INC | 514,200 | $10.89M | 1.1% | $28.11 | -6.7% | COM | 86881A100 |
| ORIC | ORIC PHARMACEUTICALS INC | 1,265,200 | $10.21M | 1.0% | $9.89 | -7.2% | COM | 68622P109 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 354,000 | $9.098M | 0.9% | $19.16 | +10.8% | ORDINARY SHARES | N62509109 |
| INCY | INCYTE CORP | 129,600 | $8.951M | 0.9% | $56.64 | +25.8% | COM | 45337C102 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 2,694,600 | $8.596M | 0.8% | $14.32 | -43.0% | COM NEW | 46489V302 |
| ASND | ASCENDIS PHARMA A/S | 62,000 | $8.536M | 0.8% | $149.31 | — | SPONSORED ADR | 04351P101 |
| BHVN | BIOHAVEN LTD | 222,900 | $8.325M | 0.8% | $35.42 | +31.7% | COM | G1110E107 |
| — | INTRA-CELLULAR THERAPIES INC | 97,000 | $8.101M | 0.8% | $52.09 | — | COM | 46116X101 |
| IMUX | IMMUNIC INC | 7,966,400 | $7.966M | 0.8% | $1.30 | -3.0% | COM | 4525EP101 |
| CNTX | CONTEXT THERAPEUTICS INC | 7,477,200 | $7.851M | 0.8% | $1.72 | +0.4% | COM | 21077P108 |
| ORKA | ORUKA THERAPEUTICS INC | 352,124 | $6.828M | 0.7% | $34.79 | -29.9% | COM | 687604108 |
| REGN | REGENERON PHARMACEUTICALS | 8,400 | $5.984M | 0.6% | $834.60 | 0.0% | COM | 75886F107 |
| BRKR | BRUKER CORP | 76,300 | $4.473M | 0.4% | $58.77 | 0.0% | COM | 116794108 |
| VERA | VERA THERAPEUTICS INC | 100,000 | $4.229M | 0.4% | $44.28 | 0.0% | CL A | 92337R101 |
| RGNX | REGENXBIO INC | 532,000 | $4.112M | 0.4% | $17.79 | -47.2% | COM | 75901B107 |
| QURE | UNIQURE NV | 222,000 | $3.921M | 0.4% | $6.51 | +32.6% | SHS | N90064101 |
| KZR | KEZAR LIFE SCIENCES INC | 502,600 | $3.377M | 0.3% | $7.45 | 0.0% | COM NEW | 49372L209 |
| KROS | KEROS THERAPEUTICS INC | 210,000 | $3.324M | 0.3% | $57.13 | -9.0% | COM | 492327101 |
| — | AKERO THERAPEUTICS INC | 82,000 | $2.281M | 0.2% | $27.82 | — | COM | 00973Y108 |
| DYN | DYNE THERAPEUTICS INC | 96,000 | $2.262M | 0.2% | $39.80 | -25.7% | COM | 26818M108 |
| COGT | COGENT BIOSCIENCES INC | 287,104 | $2.239M | 0.2% | $6.96 | +43.2% | COM | 19240Q201 |
| NMRA | NEUMORA THERAPEUTICS INC. | 150,000 | $1.59M | 0.2% | $12.81 | -6.5% | Call | 640979100 |
| SCYX | SCYNEXIS INC | 1,228,910 | $1.487M | 0.1% | $2.82 | -54.0% | COM NEW | 811292200 |
| — | KARYOPHARM THERAPEUTICS INC | 2,018,500 | $1.365M | 0.1% | $3.40 | — | COM | 48576U106 |
| HYPR | HYPERFINE INC | 1,188,178 | $1.046M | 0.1% | $9.78 | -90.2% | COM CL A | 44916K106 |
| — | BLUEBIRD BIO INC | 81,555 | $680K | 0.1% | $8.34 | — | COM NEW | 09609G209 |